Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

the Material Balance and Biotransformation Study of [14C] XZP-3287 in Healthy Chinese Male Subjects

NCT05478109 is registered in ClinicalTrials.gov with Xuanzhu Biopharmaceutical Co., Ltd. as lead sponsor.

NCT NCT05478109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05478109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
the Material Balance and Biotransformation Study of [14C] XZP-3287 in Healthy Chinese Male Subjects
Lead sponsor
Xuanzhu Biopharmaceutical Co., Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
August 2, 2022
Completion date
January 4, 2023
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy male subjects